Profil
Martin Henry Diggle is the founder of Vulpes Investment Management Ltd. Current positions include Chairman at Vulpes Life Sciences Fund, Non-Executive Director at Oxford BioDynamics Plc starting in 2026, Non-Executive Director at Proteome Sciences Plc since 2014, and Portfolio Manager at Vulpes Ventures.
Former roles include Non-Independent Non-Executive Director at Oxford Biomedica Plc from 2012 to 2021, Director & Partner at Brunswick UBS, Non-Executive Director at Scancell Holdings Plc, Non-Executive Director at Chronos Therapeutics Ltd., and Director at Leucid Bio Ltd. Education includes graduation from the University of Oxford.
Aktive Positionen von Martin Diggle
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTEOME SCIENCES PLC | Direktor/Vorstandsmitglied | 16.10.2014 |
| OXFORD BIODYNAMICS PLC | Direktor/Vorstandsmitglied | 15.04.2026 |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Vorsitzender | - |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Direktor/Vorstandsmitglied | 27.03.2015 |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Martin Diggle
| Unternehmen | Position | Ende |
|---|---|---|
| OXFORD BIOMEDICA PLC | Direktor/Vorstandsmitglied | 03.02.2021 |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Direktor/Vorstandsmitglied | 01.01.2003 |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Direktor/Vorstandsmitglied | - |
| SCANCELL HOLDINGS PLC | Direktor/Vorstandsmitglied | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Martin Diggle
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Proteome Sciences Plc
Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Finance |
Scancell Holdings Plc
Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Commercial Services |
















